About Morgan
Morgan joined Alexion in June 2018 as a member of the Investor Relations team before becoming Chief of Staff to the CEO. Prior to joining Alexion, Morgan served as a Vice President in Equity Research at Barclays plc with focused coverage on the Specialty Pharmaceuticals and Emerging Biosimilars sector. Previously, Morgan worked at Allergan plc within the pricing and reimbursement department and at Memorial Sloan-Kettering Cancer Center in the Department of Neurology.
Morgan received her MBA from the Leonard N. Stern School at New York University and her Bachelor’s degree in Neuroscience from Hamilton College.